Bone Marrow Trephine Biopsy
Bone Marrow Trephine Biopsy — 2025-11-20
Procedure Details
- Date: 2025-11-20 (sample generated 13:09, accepted 14:49)
- Facility: KIMS Health, Trivandrum
- Referring Physician: Ashwin V Nair
- Biopsy No: B25-15264
- Bill No: L085234025
- Billed at: 2025-11-20 12:50
- Authorized at: 2025-11-26 10:48 (6 days turnaround)
Clinical Indication
Complaints of pancytopenia.
Specimen
Two brownish linear cores of tissue, each measuring 0.3 cm (1 bit AE).
Histopathology Report
Microscopy
Bony core showing 6–7 fragmented marrow spaces showing extensive crushing. Focal area shows 60% cellularity with atypical mononuclear cell infiltrate admixed with normal hematopoietic precursors.
Special Stains
- Reticulin: Grade 1–2
- PAS: No additional findings
- Perls (iron stain): Inconclusive
Diagnosis
- Fragmented marrow tissue with crushing and immature cell infiltrate admixed with hematopoietic elements
- Recommendation: Please follow bone marrow aspiration / flow cytometry report
Reported By
Dr. Neetu S Dathan, MBBS, Fellowship in Oncopathology, MD Pathology
Interpretation
The biopsy shows a hypercellular marrow (60% cellularity, which is higher than expected for an 81-year-old) with an atypical mononuclear cell infiltrate. The reticulin grade 1–2 suggests early fibrosis. The extensive fragmentation and crushing limit full assessment. Flow cytometry is recommended to characterize the atypical cells — this could represent a lymphoproliferative disorder, myelodysplastic syndrome, or other infiltrative process.
Follow-up
- Bone marrow aspiration / flow cytometry — Bone Marrow Biopsy 2025 11 28 and Flow Cytometry 2025 11 28 performed 8 days later by Dr. Bijay
- Karyotype 2025 11 29 — normal 46,XX
- Oncomine Myeloid Assay NGS (bone marrow drawn 2025-11-22) — see Aml molecular profile
- Serial CBC monitoring — ongoing, showing improvement by April 2026
Updated automatically during ingest.